News
4 Things You Should Know About Benefits For People With Disabilities
People with disabilities or PwDs require assistance and support from healthcare professionals to ensure their health and overall well-being. Since disabilities significantly impair cognitive, physical, and sensory functions, proper medication and treatments are necessary. However, healthcare services for people...
Drug Research
Location of Receptor Crucial For Effects of Psychedelic Drug
For psychedelic medications to effectively cure mental disease by swiftly re-establishing connections between nerve cells, the location happens to be crucial. In a study published on February 17 in Science, scientists from the University of California, Davis, demonstrate that...
Drug Research
Glenmark Pharma receives 2nd US FDA tentative approval for generic Onglyza tablets
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received a 2nd tentative approval by the United States Food & Drug Administration (FDA) for saxagliptin tablets, 2.5 mg and 5 mg, the generic version of Onglyza tablets, 2.5 mg and 5 mg,...
Drug Research
University of East Anglia researchers make a breakthrough for next gen cancer treatment
University of East Anglia researchers make breakthrough for ‘next gen’ cancer treatment. These new treatments would be highly targeted and more effective than current state-of-the-art cancer immunotherapies.
New research published today reveals the science behind this innovative idea. It shows how...
Drug Research
New BioAccelerator Expands Biomanufacturing Capacity for Canada
The Governments of Canada and Prince Edward Island (PEI) will invest $50 million in the BioAccelerator, the largest single investment in economic development infrastructure in PEI history.
The announcement was made by Ginette Petitpas Taylor, Minister of Official Languages, who...
Drug Research
BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell receptors (TCRs).
The platform is expected to be deployed via a collaborative model with pharmaceutical and...
Drug Research
Lonza Completes Expansion of Conjugation Facility in Visp
Lonza, a partner to the pharmaceutical, biotech and nutraceutical markets, has completed a planned expansion of its bioconjugation facility in Visp, Switzerland.
The expansion includes two manufacturing suites and supporting infrastructure to support an extended customer portfolio, including companies entering...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read